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Abstract
Background: Ethical considerations play a prominent role in the protection of human subjects in clinical research.
To date the disclosure of ethical protection in clinical research published in the international nursing journals has
not been explored. Our research objective was to investigate the reporting of ethical approval and informed
consent in clinical research published in leading international nursing journals.
Methods: This is a retrospective observational study. All clinical research published in the five leading international
nursing journals from the SCI Journal Citation Reports between 2015 and 2017 were retrieved to evaluate for
evidence of ethical review.
Results: A total of 2041 citations have been identified from the contents of all the five leading nursing journals that
were published between 2015 and 2017. Out of these, 1284 clinical studies have been included and text relating to
ethical review has been extracted. From these, most of prospective clinical studies (87.5%) discussed informed
consent. Only half of those (52.9%) reported that written informed consent had been obtained; few (3.6%) reported
oral consent, and few (6.8%) used other methods such as online consent or completion and return of data
collection (such as surveys) to denote assent. Notably, 36.2% of those did not describe the method used to obtain
informed consent and merely described that “consent was obtained from participants or participants agreed to join in
the research”. Furthermore, whilst most of clinical studies (93.7%) mentioned ethical approval; 92.5% of those stated
the name of ethical committee and interestingly, only 37.1% of those mentioned the ethical approval reference.
The rates of reporting ethical approval were different between different study type, country, and whether financial
support was received (all P < 0.05).
Conclusion: The reporting of ethics in leading international nursing journals demonstrates progress, but
improvement of the transparency and the standard of ethical reporting in nursing clinical research is required.
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Background
Given the importance of protecting human subjects in
clinical research, there is now greater scrutiny of re-
searchers to ensure that ethical principles have been met
during the process [1, 2]. The World Medical Associ-
ation issued the Declaration of Helsinki in 1964 and
established the international ethical regulations for med-
ical studies involving human subjects with subsequent
updates [3]. The Declaration of Helsinki highlighted two
aspects of ethical considerations: that all of the partici-
pants have the right to be informed about the study, by
giving informed consent, and that an ethics committee
approval should have got to ensure the appropriateness
of design before initiating a research [4]. Furthermore,
journals and publishers, have a responsibility to act as
“gate-keepers”, and are obliged to scrutinize whether
ethical approval of human research has been obtained
priori to submission of papers [5]. This responsibility
mirrors the requirement of the Declaration of Helsinki
that “Researchers, authors, sponsors, editors and pub-
lishers all have ethical obligations……Reports of research
not in accordance with the principles of this Declaration
should not be accepted for publication” [4]. This duty of
journals and publishers is supported by the International
Committee of Medical Journal Editors (ICMJE) [6] and
adopted by journal editors and publishers. Following
this, the Nuremberg Code [7], the World Association of
Medical Editors (WAME) [8], and the Committee of
Publication Ethics (COPE) [9] established ethical princi-
ples to protect human right in medical research. For ex-
ample, COPE stipulated that journals should provide
guidance to support the reporting of ethical approval
and informed consent when publishing human research.
However, the reporting of ethical considerations still
less than ideal in human research though it is acknowl-
edged that some progress has made in recent years. For
example, Yank and Rennie [1] investigated the ethical
protections of clinical trials published in top five medical
journals including The Lancet, JAMA, BMJ, The New
England Journal of Medicine, and Annals of Internal
Medicine and found that 31 and 26% articles published
before 1997 did not report ethical approval and in-
formed consent, respectively. Furthermore, 18% of publi-
cations in these five journals after 1997 did not report
ethical approval and informed consent. More recently,
similar findings were identified by a range of authors,
suggesting that this is a common challenge faced by
journals [10–17]. For example, Schroter, Plowman [10]
reviewed five general medical journals and reported that
47 and 31% of human research did not describe whether
informed consent and ethical approval have obtained.
More recently, the increasing concern on human rights
protection has influenced this and ethical transgressions
have improved. This was illustrated by Bridoux, Schwarz
[18], who reported that 92.2% of surgical trials described
informed consent and 87.7% stated ethical approval.
However, publications that are not in accordance with
the principles of ethical reporting remains common [19–
22]. For example, Murphy, Nolan [20] identified that
42.9 and 49.9% of clinical research published in three
leading European Otolaryngology periodicals did not re-
port informed consent and ethical approval, respectively.
Nursing research has progressed rapidly during the
last three decades and supported the development of ef-
ficient and high-quality care. This is observed in a num-
ber of nursing academic journals, increased volume of
nursing research, and professors in nursing [23–25]. The
growth in nursing research presents a range of chal-
lenges, not least because of the vulnerable groups that
nursing research includes and the capability and capacity
of nurses to conduct ethically sound research. Worry-
ingly, it is acknowledged that many nurses receive inad-
equate education, often compounded with lack of ethical
awareness and knowledge when conducting clinical re-
search [26–29]. This was reflected in findings reported
by Negarandeh and Gobady [30] who identified that
70.8% of nurses and midwives lack of education on eth-
ical issues. These challenges within nursing research has
raised concerns and the International Council of Nurses
Code of Ethics for Nurses [31] has founded to regulate
research ethics in the nursing profession. Therefore, it is
essential to identify the extent to which ethical review is
reported in nursing publications to both regulate and
monitor ethics in nursing research involving human
subjects.
Currently, the majority of ethics investigation have fo-
cused on reports in medical journals. In order to identify
the extent to which ethical approval on human research
is reported in nursing journals, we conducted a study to
explore the ethical considerations among 12 Chinese top
nursing journals. Our findings identified that only 51.8
and 25.9% of clinical trials reported informed consent
and ethical approval, respectively [32]. The purposes of
this study were to assess the rates of reporting of ethical
considerations in five leading international nursing jour-
nals following the work of Yank and Rennie [1].
Methods
Study design and inclusion criteria
This is a retrospective observational study adhered to
STROBE guidelines. All publications that reported clin-
ical research in five high ranked nursing journals, ac-
cording to the 2017 SCI Journal Citation Reports’ impact
factor between 2015 and 2017 were retrieved to evaluate
for evidence of ethical review. These journals, with a
high impact factor, were International Journal of Nursing
Studies (3.755), European Journal of Cardiovascular
Nursing (2.763), Journal of Family Nursing (2.537), Nurse
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Education Today (2.533), and Birth-issues in Perinatal
Care (2.518). Publications were included if the following
criteria were met: (1) Clinical research articles: as de-
scribed by previous studies [10, 11, 13, 20], the sample
frame selected included all original research articles in-
volving human participants or human tissue. (2) Full-
text articles. Supplement published studies, protocols, la-
boratory and animal studies, reviews, letters, editorials,
discussion papers, erratum/corrigendum, commentaries,
and news were excluded.
Data extraction
Data were extracted between August 2017 and July
2018. The contents and full-text PDFs of the five top
nursing journals between 2015 and 2017 were extracted
and downloaded from the Wiley Online Library or the
ScienceDirect through the university subscription. Two
authors (W.C and M.H1) independently reviewed the ar-
ticles published in the five nursing journals in keeping
with the standardized eligibility criteria to ensure the ac-
curacy and credibility of the process. All of the articles
were identified and reviewed based on the contents of
each issue of journal. The full text of each included art-
icle was carefully read and the results were recorded in a
standardized data extraction form. Disagreements were
resolved by consensus or the third person (Y.W). Fol-
lowing this, articles that did not report ethical review
were checked again by the third person (Y.W).
The primary outcome of our study was to ascertain
the rates of reporting informed consent and ethical ap-
proval. We included papers with any of the following
types descriptions (with examples). (1) Informed consent
– a. written informed consent obtained (“the written in-
formed consent was obtained from participants or the le-
gally authorized representative”), b. oral informed
consent obtained (“the oral/verbal consent was obtained
from participants”), c. other consent type (has been cate-
gorized as “the participants’ consent was indicated by the
completion and returning of the questionnaire”, “consent
was obtained through providing information and finish-
ing consent section or a consent form within the online
portal”, and “the informed consent was indicated by par-
ticipants take part in evaluations”), d. the consent type
not reported (only described that “consent was obtained
from participants or participants agreed to join in the re-
search”, but did not indicate the way to get the consent),
and e. consent was waived or not required (“informed
consent was exempted or not required due to the policy
or the law of the government or the type of the research”).
The dates on informed consent in the study were col-
lected on prospective studies only [20]. (2) Ethical ap-
proval – we checked to determine if the study reported
that it was approved by the ethics committee in the hos-
pital or other institutions before undertaking the
research. We also examined whether the name of the
ethical committee and ethical approval reference num-
ber was reported.
The secondary outcomes of our study included the
rates of reporting other details related to ethical approval
and informed consent including ethical statement. For
example, whether the author declared that the research
conformed to the Declaration of Helsinki, and if the re-
search participants had been told that they have the
right to withdraw from the study at any time without re-
prisal. There was excellent agreement on the two pri-
mary outcome measures between two authors (W.C and
M.H1) (reporting of informed consent and ethical ap-
proval) (k > 0.95 for all).
We collated additional information that included the
study type, funding sources, and nationality of publish-
ing institution to enable subgroup analysis. Firstly, the
type of research was categorized as either prospective or
retrospective based on prior studies [11, 13, 15]. Follow-
ing this, the prospective studies were divided into ran-
domized controlled trial (RCT), nonrandomized trial,
observational study (including audit, surveys, quality as-
surance activities, prospective cohort study, and qualita-
tive study), single-arm, specimen, and mixed methods
study. The retrospective studies were divided into speci-
men, chart review, and database analysis. Secondly, data
were gathered on whether research received financial
support following the work of Yank and Reinnie [1], re-
gardless of the type of funding. Finally, given the differ-
ent clinical ethical dilemmas in different countries [33],
we identified the nationality of publishing institution of
each study, defined as the country of the research con-
ducted institution.
Data analysis
Data was analyzed using SPSS 20.0 software (IBM,
USA). The rates of informed consent and ethical ap-
proval between year, study types, funding sources, and
different countries were compared by use of Chi-square
tests or Fisher’s exact tests (where cell size was less than
5). All P values were two-sided, and a value of P < 0.05
was indicated significant.
Results
Study selection
A total of 2041 citations were identified from the con-
tents of all the five leading nursing journals published
between 2015 and 2017. From these, 757 were screened
out using the data extraction process. These were: 335
reviews, one laboratory investigation, one research
protocol, and 420 other types (letters, editorials, discus-
sion papers, erratum/corrigendum, commentaries, and
news). In total, 1284 clinical papers were included to ex-
tract the data of ethical review (see Fig. 1).
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Informed consent
Of the 1284 clinical studies, 99 were retrospective stud-
ies and 1185 were prospective studies. Of the 1185 pro-
spective studies, 1037 (87.5%) mentioned informed
consent. However, only 549 (52.9%) of those reported
that written informed consent had been obtained, and
only 37 (3.6%) of these had reported oral consent. Inter-
estingly, 70 (6.8%) of studies had used other ways to in-
dicate participants’ consent, such as ‘assent’ through the
completion and return of the questionnaire in surveys,
or finishing online consent section, or implied by partici-
pants attend research evaluations. Notably, a small num-
ber 375 (36.2%) described that “consent was obtained
from participants or participants agreed to join in the re-
search” but did not elaborate on the methods used to
gain consent. Furthermore, six (0.5%) studies stated that
the informed consent from participants were waived or
not required due to the policy or the law of the govern-
ment or the type of the research (Table 1). In addition,
the rates of reporting informed consent between differ-
ent publication years and evidence of research funding
demonstrated no statistical significance (all P > 0.05) but
variances were observed between different country (P <
0.001) (Table 2).
Ethical approval
Our results indicate that 1203 (93.7%) of 1284 clinical
studies reported ethical approval in the main text of the
paper. Of the 1203 studies, 1144 (95.1%) reported that
ethics committee approval was obtained before the study
was undertaken and 59 (4.9%) of studies stated that the
ethical approval for the study was not required or waived
under the local or national laws. Notably, of the 1144
studies that reported ethical approval had been obtained,
a larger number, 1058 (92.5%) of studies stated the name
of ethical committee, however, only 424 (37.1%) of stud-
ies included the ethical approval reference number. A
small number, 181 (14.1%) of studies stated that ethical
considerations of the research conformed to the Declar-
ation of Helsinki (Table 1). Furthermore, no statistically
significant differences were found between 2015 and
2017 in relation to the rates of reporting ethical approval
(P > 0.05). Notably, the rates of reporting ethical ap-
proval were different between different study type, coun-
try, and whether mentioning financial support (all P <
0.05). The rates of reporting ethical approval in pro-
spective studies was much higher than retrospective
studies (94.6% vs 82.8%). Moreover, the reporting of eth-
ical approval in the studies that had financial support,
was much higher than those who did not receive funding
(95.2% vs 91.9%) (Table 2).
Discussion
Our findings revealed a relative progression in the
reporting of ethics as compared with prior studies such
as Yank and Rennie [1], Schroter, Plowman [10], Pitak-
Arnnop, Sader [14], and Fitzgerald [19]. For example, we
identified that 87.5% of prospective clinical studies re-
ported informed consent and 93.7% of clinical studies
stated that ethical approval had been obtained. This is
similar to Bridoux, Schwarz [18] findings that reported
87.7 and 92.2% of surgical trials stated ethical approval
and informed consent, respectively. However, the report-
ing rates of ethics were much higher than most of other
studies. For example, informed consent and ethical ap-
proval were reported in 53 and 69% in five general
Fig. 1 PRISMA Flow Diagram
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Table 2 Reporting of informed consent and ethical approval in clinical research in leading nursing journals between 2015 and 2017
Items Number of
clinical researches
Number of
Prospective studies
N (%)
Informed consent reported Ethical approval reported
Year
2015 398 364 (91.5) 328 (90.1) 376 (94.5)
2016 510 477 (93.5) 411 (86.2) 477 (93.5)
2017 376 344 (91.5) 298 (86.6) 350 (93.1)
X2 0.462 0.045
P value 0.794 0.978
Study type
Prospective studies 1185 – 1037 (87.5) 1121 (94.6)
Randomized controlled trial 122 – 113 (92.6) 119 (97.5)
Nonrandomized trial 62 – 52 (83.9) 61 (98.4)
Observational study 835 – 734 (87.9) 792 (94.9)
Single-arm 66 – 52 (78.8) 55 (83.3)
Specimen 0 – 0 0
Mixed methods study 100 – 86 (86.0) 94 (94.0)
Retrospective studies 99 – – 82 (82.8)
Specimen 0 – – 0
Chart review 21 – – 20 (95.2)
Database analysis 78 – – 62 (79.5)
P value – < 0.001
Mentioning financial support
Yes 702 662 (94.3) 587 (88.7) 668 (95.2)
No 582 523 (89.9) 450 (86.0) 535 (91.9)
P value 0.185 0.021
The country of conducting the research
US 186 155 (83.3) 127 (81.9) 175 (94.1)
Australia 148 137 (92.6) 118 (86.1) 147 (99.3)
UK 144 136 (94.4) 111 (81.6) 138 (95.8)
China 124 119 (96.0) 107 (90.0) 118 (95.2)
Sweden 69 63 (91.3) 59 (93.7) 66 (95.7)
≥ 2 countries 63 59 (93.7) 48 (81.4) 52 (82.5)
Canada 60 55 (91.7) 51 (92.7) 58 (96.7)
Netherlands 47 44 (93.6) 39 (88.6) 42 (89.4)
Spain 43 40 (93.0) 35 (87.5) 31 (72.1)
Korea 43 41 (95.3) 39 (95.1) 43 (100)
Turkey 33 33 (100) 33 (100) 28 (84.9)
Norway 25 23 (92.0) 22 (95.7) 24 (96.0)
Italy 25 23 (92.0) 21 (91.3) 23 (92.0)
Japan 19 16 (84.2) 15 (93.8) 19 (100)
Finland 17 16 (94.1) 14 (87.5) 15 (88.2)
Ireland 17 16 (94.1) 12 (75.0) 13 (76.5)
Singapore 17 17 (100) 16 (94.1) 16 (94.1)
Israel 16 12 (75.0) 9 (75.0) 16 (100)
Germany 15 14 (93.3) 11 (78.6) 13 (86.7)
Denmark 14 14 (100) 14 (100) 13 (92.9)
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Table 2 Reporting of informed consent and ethical approval in clinical research in leading nursing journals between 2015 and 2017
(Continued)
Items Number of
clinical researches
Number of
Prospective studies
N (%)
Informed consent reported Ethical approval reported
Belgium 13 13 (100) 12 (92.3) 13 (100)
Iran 13 13 (100) 12 (92.3) 13 (100)
Jordan 11 11 (100) 10 (90.1) 10 (90.1)
Brazil 11 10 (90.1) 9 (90.0) 11 (100)
France 9 7 (77.8) 5 (71.4) 8 (88.9)
New Zealand 8 6 (75.0) 4 (66.7) 8 (100)
Switzerland 8 8 (100) 8 (100) 7 (87.5)
Thailand 7 7 (100) 6 (85.7) 7 (100)
South Africa 6 6 (100) 6 (100) 6 (100)
Greece 5 5 (100) 4 (80.0) 5 (100)
Poland 5 5 (100) 5 (100) 5 (100)
Portugal 5 5 (100) 5 (100) 5 (100)
Iceland 4 3 (75.0) 3 (100) 3 (75.0)
India 4 4 (100) 3 (75.0) 4 (100)
Indonesia 4 4 (100) 3 (75.0) 4 (100)
Malaysia 4 4 (100) 4 (100) 4 (100)
Lebanon 4 4 (100) 4 (100) 4 (100)
Philippines 4 4 (100) 4 (100) 4 (100)
Saudi Arabia 4 4 (100) 2 (50.0) 3 (75.0)
Croatia 3 3 (100) 2 (66.7) 3 (100)
Afghanistan 2 2 (100) 2 (100) 2 (100)
Africa 2 2 (100) 2 (100) 2 (100)
Chile 2 1 (50.0) 1 (100) 2 (100)
Mexico 2 2 (100) 2 (100) 2 (100)
Nepal 2 2 (100) 2 (100) 2 (100)
Oman 2 2 (100) 2 (100) 2 (100)
Brunei 1 1 (100) 1 (100) 1 (100)
Dutch 1 1 (100) 1 (100) 1 (100)
Egypt 1 1 (100) 1 (100) 1 (100)
Ethiopia 1 1 (100) 1 (100) 1 (100)
Florida 1 1 (100) 1 (100) 1 (100)
Lithuania 1 1 (100) 1 (100) 1 (100)
Madagascar 1 1 (100) 1 (100) 0
Malawi 1 1 (100) 1 (100) 1 (100)
Nigeria 1 1 (100) 1 (100) 1 (100)
Pakistan 1 1 (100) 1 (100) 1 (100)
Palestine 1 1 (100) 1 (100) 1 (100)
Qatar 1 1 (100) 1 (100) 1 (100)
Serbia 1 1 (100) 1 (100) 1 (100)
Slovenia 1 1 (100) 0 1 (100)
Srilanka 1 1 (100) 1 (100) 1 (100)
P value < 0.001 < 0.001
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medical journals, 68.5 and 71% in six leading anesthesia
journals, 36 and 39.3% in four major orthodontic jour-
nals, 57.1 and 50.1% in three leading European Oto-
laryngology journals, as well as 16 and 54% in three
paediatric surgical journals, respectively [10, 11, 19, 20,
22]. Furthermore, the reporting of ethical considerations
in the five leading international journals was more fre-
quent than the twelve top Chinese nursing journals we
previously investigated in 2017. These earlier findings
highlighted that only 51.8 and 25.9% of clinical trials
stated informed consent and ethical approval, respect-
ively [32]. This more recent increase may have been in-
fluenced though the rapid development of medical
technology which has enriched the content of nursing
clinical research. However, it is acknowledged that
China’s higher nursing education developed slowly be-
cause of civil wars and external invasion until 1949 and
still need more efforts to improve the knowledge and
awareness of ethics among nursing researcher [34].
Importantly, our findings indicated that the reporting
of ethical approval in leading international nursing jour-
nals is less than ideal and work is needed to develop a
standardized approach. Whilst our research illustrates a
welcome progression, equally, the reporting of ethical
approval is now recognized by leading journals as an es-
sential pre-publication requirement. However, the detail
of what is reported needs to be developed to enable
readers and editors to understand that the reporting of
consent was more than just ‘consent’ and that it was
truly informed, thus reflecting the autonomous rights of
the research participants. Merely stating fact that ‘in-
formed consent’ was obtained, does not necessarily
mean that consent was actually informed [1]. Signing a
consent form or explicitly negotiated verbal consent pre-
sents two traditional methods in which participants’ in-
formed consent is obtained [3]. With the rapid
development of network techniques, using electronic
methods to obtain informed consent is now considered
to be a convenient as compared to other ways especially
in some online questionnaire survey research. Further-
more, based on the 375 studies that did not describe the
way to get the consent, determining whether the ethical
considerations reported were implemented as challen-
ging. Moreover, the reason for exemption should be de-
clared by the authors which should include a rationale
for absence of informed consent and/or ethical approval.
For example, lack of informed consent maybe as a result
of fully anonymised samples or legal reasons [15]. In our
study, only 59 (4.9%) of studies stated that the ethical
approval for the study was not required or waived under
the local or national laws. Of the studies that have been
identified as not reporting ethical considerations, we are
unable to report whether the ethical protections of these
studies were deemed unnecessary or if the researcher
did not consider it. Therefore, the reporting of ethical
protection of clinical research in leading nursing journals
needs to be transparent and standardized.
Furthermore, our study identified progression in the
reporting of ethical approval, however, only 37.1% of
studies mentioned the ethical approval reference num-
ber. Although the ethical principles of the Declaration of
Helsinki and the ICMJE do not stipulate that authors re-
port the name of ethics committee and the approval
number in the text, it has been recommended by many
researchers [1, 20, 35]. Similar reporting expectations
are included in the author instructions in numerous
medical journals such as the BMJ, the European Journal
of Cardiovascular Nursing, and the Journal of Family
Nursing. This conflict in reporting of ethical committees
and references numbers could be explained by the fol-
lowing two reasons. Firstly, the inclusion of the ethics
committee details and reference helps to regulate ethical
statement and to make sure that the ethical approval is
authentic. Secondly, there is strong evidence to show the
different effectiveness and practice between different
local committees, stating the name of ethics committee
could also help readers or others make decisions on the
ethical protections of the study [36, 37]. In addition, our
study, only five clinical studies stated the organizational
approval to conduct the research including the approval
from the dean’s office, the school management, and the
head of the department. Though this may be due to the
organization policy, this approach does not comply with
the principles of the Declaration of Helsinki which states
that the research should be approved by an independent
ethics committee. Therefore, the statement of the ethics
committee approval in clinical studies still need to be
standardized and improved.
It was surprising that there was no difference between
publication year on ethical considerations in leading
international nursing journals, which is contrary to the
results on twelve Chinese nursing journals demonstrated
a sharp improvement previously identified between 2013
and 2016 [32]. This may have been influenced by recent
higher education institution, the ethics committee, and
the nursing journals efforts in China in recent years.
Furthermore, our research demonstrated that the rates
of reporting ethical approval in prospective studies was
much higher than retrospective studies (94.6% vs 82.8%).
Specifically, RCTs showed a relatively high reporting
rates whereas the study type of database and single-arm
need more attention to improve the reporting of ethical
considerations. This is supported by Block [13] who
found that the RCTs showed a high proportion in
reporting of ethical approval. Most of researchers ob-
tained ethics committee approval for RCTs and were not
realized that approval still required for studies that do
not enroll human participants such as retrospective
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studies on chart or database review [15]. Moreover, al-
though we only retrieved the rates of reporting informed
consent in prospective studies in line with prior studies
[13, 20], we are aware that neither retrospective studies
published in the five leading international nursing jour-
nals stated the informed consent. The Declaration of
Helsinki states that if informed consent for medical re-
search using existing human data or material is imprac-
ticable to obtain, the research could be done after
approval of an ethics committee. Furthermore, some re-
searchers also stated that the informed consent is not re-
quired to the retrospective studies because this kind of
study meet the criteria that “the research involves no
more than minimal risk to the subjects” [13].
Conclusion
In summary, nursing journals assume an extremely im-
portant social, moral and ethical responsibility to improve
and regulate the reporting of ethical considerations in
clinical research. The reporting of ethics in the five leading
international nursing journals showed some progress, but
effort is still required to standardize the transparency and
detail of ethical reporting.
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